Physician profile
Kevin Garner
NPI 1922159037
$372.48
in general payments reported to CMS, 2019-2025
9 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $75.77 · 2023: $40.28 · 2024: $57.81 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258 · Education: $38.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.17 |
| Education | $38.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $89.55 | 2025 | Cobenfy |
| Abbvie INC. | $75.94 | 2023-2025 | |
| Orexo US, INC. | $75.77 | 2021 | |
| Lundbeck LLC | $38.54 | 2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $23.06 | 2024 | Invega Sustenna |
| Braeburn INC. | $21.49 | 2024 | Brixadi |
| Viiv Healthcare Company | $18.21 | 2023 | Apretude |
| Pfizer INC. | $16.66 | 2025 | |
| Indivior INC. | $13.26 | 2024 | Sublocade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Garner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.